|
1. Biologie
|
|
|
|
2.6 Etiologie - Environnement
|
|
|
|
Parental exposure to hazardous agents tied to eye tumors in offspring [Reuters]
|
|
|
|
|
|
The
research team studied 282 children with sporadic retinoblastoma, plus
155 of the children’s healthy friends, as well as all the parents.
Fathers were asked to report all jobs held in the ten years prior to
conception. Mothers reported jobs held the month prior to conception in
addition to any jobs they had while pregnant.
|
|
|
|
|
|
|
|
3.3 Prévention - Vaccins
|
|
|
|
|
3.7 Prévention - Alcool
|
|
|
|
Cancer Doctors Cite Risks of Drinking Alcohol [NY Times]
|
|
|
|
|
|
“The
message is not, ‘Don’t drink.’ It’s, ‘If you want to reduce your cancer
risk, drink less. And if you don’t drink, don’t start,’” said Dr.
Noelle LoConte, an associate professor at the University of
Wisconsin-Madison and the lead author of the ASCO statement.
|
|
|
|
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
Breast cancer – can prevention become more personalised? [PHG Foundation]
|
|
|
|
|
|
As
part of the PROCAS study, researchers have developed a genetic test to
assess small variations in a number of genes (single nucleotides
polymorphisms, or SNPs), that collectively may increase the risk of
breast cancer, and that might be present in women with family history of
breast cancer but who do not carry a high-risk BRCA1/2 gene mutation.
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
5.12 Immunothérapies
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
|
5.12.3 Immunothérapies-combinaisons
|
|
|
|
5.12.9 Immunothérapies - SITC
|
|
|
Acess SITC 2017 Abstracts [The Sentinel]
|
|
|
|
|
|
The
Society for Immunotherapy of Cancer (SITC) received a record-breaking
number of abstracts in 2017 for its Annual Meeting, marking a 21 percent
increase in submissions compared to last year.
|
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
Novartis cancer drug Kisqali succeeds in late-stage trial [Rfeuters]
|
|
|
|
|
|
In
the so-called MONALEESA-7 trial, Kisqali (ribociclib) combination
therapy met its primary endpoint of progression-free survival in
premenopausal women with hormone-receptor positive, human epidermal
growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer.
|
|
|
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
EMA gets ready for relocation decision [EMA]
|
|
|
|
|
|
With
less than two weeks to go before EU Member States select a new host
city for the European Medicines Agency (EMA) on 20 November 2017, the
Agency prepares itself to immediately start working with the new host
country.
|
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
6.1 Observation
|
|
|
|
|
|
|
|
6.10 Politiques
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.6 Publications
|
|
|